bioRxiv · 10.1101/2023.02.09.527464
An algorithm that combines machine learning ensemble modeling and network analysis to predict self-tolerant tumor-associated antigens for anti-cancer immunotherapy
Abstract
Tumor-associated antigens (TAAs) and their derived peptides constitute the chance to design off-the-shelf mainline or adjuvant anti-cancer immunotherapies for a broad array of patients. Here, we present a computational pipeline that selects and ranks candidate antigens in a multi-pronged approach and applied it to the case of uveal melanoma. In addition to antigen expression in the tumor target and in healthy tissues, we incorporated a network analysis-derived antigen indispensability index motivated by computational modeling results, and candidate immunogenicity predictions from a machine learning ensemble model on peptide physicochemical characteristics.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Vera Gonzalez, J., Eberhardt, M., Lischer, C., Weich, A.. 2023-02-10. An algorithm that combines machine learning ensemble modeling and network analysis to predict self-tolerant tumor-associated antigens for anti-cancer immunotherapy. https://doi.org/10.1101/2023.02.09.527464
Cite the original work for its findings. Save a collection to share your selection of sources.